A pharmaceutical company waited too long to bring claims accusing its attorney from Fox Rothschild LLP of passing trade secrets covering a cancer drug to a rival, a New Jersey federal court said.
Beta Pharma Inc.'s 2023 suit came well over three years after Inventis Biotechnology Co. should have known about the alleged theft of secrets regarding its new drug, according to a Dec. 31 opinion in the US District Court for the District of New Jersey. Disclosure through InventisBio’s US patent, rejection of Beta’s own application because of that patent, and attorney Wangshen Jerry Liu’s alleged confession to Beta’s ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.